Navigation Links
Demand for DrugDev Spark™ Soars Among Small Biotechs and Pharma Seeking Best-in-Class Technology for Clinical Trial Planning, Startup and Conduct
Date:9/12/2017

DrugDev, a QuintilesIMS company, continues to strengthen its position as the clinical technology provider for small to mid-size biotechs and pharma worldwide with continued adoption of the DrugDev Spark™ unified clinical trial suite.

Sponsors unfamiliar with DrugDev Spark can experience solutions for site selection and activation, eConsent, site payments and site engagement with hands-on technology demonstrations and best practice discussions at a series of educational “Clinical Coffee” events. Register here to attend the live session scheduled for September 27 from 9am-12pm ET in Parsippany, New Jersey.

DrugDev’s growth has come as a result of proven success improving clinical trials across therapeutic areas with sponsors of all sizes in addition to Top 20 global pharmaceutical clients.

Watch a rare disease webinar with Alnylam and AMO Pharma discussing how to use technology to design and conduct more efficient and effective clinical research.

“Clinical innovation isn’t reserved exclusively for Top 20 Pharma trying to build their brand as a sponsor of choice,” said DrugDev Chief Commercial Officer Brett Kleger. “Increasingly, smaller pharmas and biotechs are adopting DrugDev Spark to improve site relationships and productivity, elevate their CRO, and support internal study teams with efficient automation tools. Scalable technology like ours is flexible enough for any budget, and levels the playing field for smaller sponsors and biotechs worldwide.”

To learn how DrugDev Spark is changing the game for smaller pharmaceutical companies, begin a conversation or request a demo at http://www.drugdev.com.

About DrugDev
DrugDev, a QuintilesIMS company, helps the world do more trials through industry-wide collaboration, standardization and a beautiful technology experience. DrugDev Spark™, the unified clinical operations suite, is comprised of proven solutions used by 85 sponsors and CROs on nearly 2,000 clinical trials to transform the quality and efficiency of clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why 9 of the top 10 sponsors and 4 of the top 5 CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.

Read the full story at http://www.prweb.com/releases/2017/09/prweb14677792.htm.


'/>"/>
Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved


Related biology technology :

1. AMRI’s Global Analytical Services Introduces Comprehensive Forced Degradation Services To Meet Pharmaceutical Industry Demand
2. Franz's Allegro Common Lisp Meets Demand for High Performance Artificial Intelligence and IoT Applications
3. Cannabis Companies Continue to Invest in Infrastructure and Grow Facilities to Keep up With Rising Demand
4. Nanobiotechnology - Global Strategic Business Report 2015-2022 - Demand for Novel Products to Push Up Growth - Research and Markets
5. SSCI Expands Biochemistry Services to Meet Growing Industry Demand
6. CohBar Inc. Presentation Now Available for On-Demand Viewing
7. SpineFrontier Enhances the MISquito Percutaneous Pedicle Screw System in Response to Growing Demand
8. Continuous Flow Chemistry Methods Revealed in On-Demand Webinars from METTLER TOLEDO
9. Demand of Amyloglucosidase Market to 2020 Analysed with Sales, Manufacture Share and Type
10. Chi-Med webcast presentation now available for on-demand viewing: Deutsche Bank ADR Virtual Investor Conference
11. Global Biomaterials Market - By Type, Application, Regions - Market Size, Demand Forecasts, Industry Trends and Updates (2014- 2020)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Tbilisi, Georgia (PRWEB) , ... October 11, 2017 , ... ... disaster, taking the lives of over 5.5 million people each year. Especially those living ... the greenovative startup Treepex - based in one of the most pollution-affected countries globally ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights ... (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital ...
(Date:10/10/2017)... , Oct. 10, 2017 SomaGenics announced the ... NIH to develop RealSeq®-SC (Single Cell), expected to be ... small RNAs (including microRNAs) from single cells using NGS ... the need to accelerate development of approaches to analyze ... "New techniques for measuring levels of mRNAs ...
(Date:10/9/2017)... ... October 09, 2017 , ... The award-winning American Farmer television series will ... American Farmer airs Tuesdays at 8:30aET on RFD-TV. , With global population estimates ... of how to continue to feed a growing nation. At the same time, many ...
Breaking Biology Technology:
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/4/2017)...   EyeLock LLC , a leader of iris-based ... Patent and Trademark Office (USPTO) has issued U.S. Patent ... an iris image with a face image acquired in ... 45 th issued patent. "The ... the multi-modal biometric capabilities that have recently come to ...
(Date:3/30/2017)...  On April 6-7, 2017, Sequencing.com will host the ... hackathon at Microsoft,s headquarters in Redmond, Washington ... developing health and wellness apps that provide a unique, ... is the first hackathon for personal genomics and ... in the genomics, tech and health industries are sending ...
Breaking Biology News(10 mins):